Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMineral & Financial Investments Regulatory News (MAFL)

Share Price Information for Mineral & Financial Investments (MAFL)

Share Price is delayed by 15 minutes
Get Live Data
48.00    0.00 (0.00%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £18.65m
MAFL Live PriceLast checked at - London Stock Exchange

Intraday Mineral & Financial Investments Share Chart

Net Asset Value Update

6 Sep 2016 08:59

RNS Number : 0544J
Mineral & Financial Invest. Limited
06 September 2016
 

MINERAL & FINANCIAL INVESTMENTS LIMITED

("Mineral & Financial", "MAFL", or the "Company")

 

 NET ASSET VALUE UPDATE

 

MAFL, the AIM quoted resources investment specialist, today announces an NAV and operations update on its activities for the period ended 30 June 2016.

 

 

· Net Asset Value of 7.45p per share (unaudited)

· Profitable disposal of Zinc ETF

· New position in silver

· Progress continues on TH Crestgate Iberian asset portfolio

· Continuing to seek further strategic investments

 

 

CHAIRMAN'S STATEMENT

The UK capital markets were initially thrown into a maelstrom of uncertainty due to the unexpected "Exit" Brexit vote. The most notable impact on Metals & Mining markets and M&FI is that the weaker British Pound has buoyed upwards commodity prices in GBP.

We believe that precious metals appear to have found their lows in the first few weeks of 2016 but that base metals are a little more mixed. We believe that bulk commodities continue to be guided by currency movements, while long neglected commodities such as zinc and lead continue to find new believers in the strong fundamentals underpinning their supply/demand relationship.

There is a lot of industry interest in battery technology, specifically lithium. We agree that portable electric power is to be a dominant theme in the metals market for the next few years. We are, however, seeking to find alternative paths to benefit from these very real and dominant trends.

Our weighting between tactical holdings and strategic holdings is likely to change over time. We have invested our liquid capital prudently in the metals and mining equities to ensure that investors continue to benefit from exposure to the sector.

Now that we have begun our programme of strategic investments our tactical weighting is likely to diminish. Accordingly the strategic element of our portfolio is likely to make up more of our net asset value on a percentage basis in the future.

We believe that there will be opportunities to invest in the precious metals cycle taking shape over the next few months. We are currently evaluating a few opportunities for your benefit and hope to report some progress on this front.

Jacques Vaillancourt

CHIEF INVESTMENT OFFICER'S STATEMENT

 

During the period the mining equity markets continued with their modest recovery and it was pleasing to see zinc in the forefront of this. The Company has significant exposure to zinc through its minority holding in TH Crestgate, the Swiss company which owns polymetallic projects in the Iberian pyrite belt.

 

With this exposure in mind, and in the context of continuing strength in the zinc price, the directors decided to take profits on the Zinc ETF which the company had held for a couple of years now.

 

The rise in Net Asset Value to 7.45p came largely as a result of a revaluation of our investment in Cap Energy, undertaken as part of an annual review of our unquoted holdings.

 

The directors have opted to apply a highly conservative discount to the price at which Cap last raised money in valuing our own holding, but were nonetheless pleased to see the uplift that the revaluation generated.

 

Some of the proceeds from this sale were then used to purchase a new silver ETF ahead of the timely run on silver that took place in the later part of June. This position is already showing a significant profit.

 

The values of our gold and platinum positions also improved during the period.

 

The Company also disposed of its residual stake in ISDX-quoted Milamber holdings for cash. 

 

While remaining cautious, it is encouraging to see markets continuing to open up, particularly the high levels of activity in Canada, which have not abated over the summer.

 

Finally, we note that TH Crestgate has agreed to an extension of the option agreement it signed with Ferrum Crescent on its Spanish portfolio suite.

 

We continue to assess opportunities at all levels, both in terms of the strategic and the tactical portfolio.

 

 

Alastair Ford

 

 

 

 

For more information:

Katy Mitchell, WH Ireland +44 161 832 2174

Laurence Read, Director +44 20 3289 9923

 

Notes: The net asset value calculation is subject to audit and is made on the basis that the Company has 24,034,562 shares in issue. All listed investments, including investments on ISDX, are valued at the closing bid price as at 30 June March 2016. The Company has an investment in one unquoted gold company that is currently valued at the price at which the gold company in question last raised money, although this is subject to review. The Company also has an investment in one unquoted zinc and base metals company, the valuation of which is subject to quarterly review and is currently recognized at cost.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVUNVBRNNAKRRR
Date   Source Headline
28th May 20269:22 amRNSHolding(s) in Company
18th Mar 20267:00 amRNSInterim Results
30th Jan 20263:09 pmRNSConversion Of Vested RSUs into Ordinary Shares
28th Jan 20267:00 amRNSHolding(s) in Company
27th Jan 202611:38 amRNSHolding(s) in Company
20th Jan 20261:06 pmRNSResult of AGM
20th Jan 20267:00 amRNS1st Quarter Results
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
7th Oct 20252:35 pmRNSDirector/PDMR Shareholding
20th Aug 20258:45 amRNSGrant of RSU's and Exercise of Options
14th Jul 202511:22 amRNSUpdate on Redcorp's Lagoa Salgada EIA Application
12th Jun 20256:18 pmRNSHolding(s) in Company
6th Jun 20259:39 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSUnaudited Quarterly Results
22nd May 20255:28 pmRNSDirector/PDMR Shareholding
7th May 20255:21 pmRNSDirector/PDMR Shareholding
7th May 20254:26 pmRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSIssue of Equity
20th Mar 20255:13 pmRNSInvestment in Physical Silver
20th Mar 20257:00 amRNSInterim Results for Six Months Ended 31 Dec 24
7th Mar 202511:45 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSInvestment Update: Ascendant
22nd Jan 202512:20 pmRNSDirector/PDMR Shareholding
16th Jan 20251:24 pmRNSReplacement: Unaudited Quarterly Net Asset Value
16th Jan 20257:00 amRNSUnaudited Quarterly Net Asset Value
18th Dec 20242:52 pmRNSResult of AGM
11th Dec 202411:05 amRNSInvestment Update: Ascendant / Redcorp
25th Nov 20242:37 pmRNSHolding(s) in Company
19th Nov 20245:53 pmRNSAudited Results for Year Ended 30 June 2024
1st Nov 202411:03 amRNSInvestment Update: Ascendant / Redcorp
15th Oct 202411:00 amRNSInvestment Update: Redcorp
30th Sep 202411:00 amRNSInvestment Update: Ascendant / Redcorp
19th Sep 20247:00 amRNSInvestment Update: Ascendant / Redcorp
17th Jul 20247:00 amRNSInvestment Update: Redcorp
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
12th Jul 20247:00 amRNSDirector Update
13th Jun 20247:00 amRNSUnaudited Quarterly Net Asset Value
29th Apr 20247:00 amRNSDirector Dealing
10th Apr 20244:22 pmRNSHolding(s) in Company
10th Apr 202411:00 amRNSInvestment Update: Ascendant / Redcorp
27th Mar 20247:00 amRNSInterim Results for Six Months Ended 31 Dec 23
29th Feb 20241:01 pmRNSCorrection - Investment Update: Ascendant /Redcorp
29th Feb 20247:00 amRNSInvestment Update: Ascendant / Redcorp
5th Feb 20247:00 amRNSUnaudited Quarterly Net Asset Value
31st Jan 20246:04 pmRNSResult of AGM
8th Jan 20247:00 amRNSDirector Dealing
3rd Jan 202411:00 amRNSInvestment Update: Ascendant / Redcorp
28th Dec 20232:29 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20235:25 pmRNSAudited Results for Year Ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.